Dycom Industries Inc

Most Recent

  • uploads///Fidelity Blue Chip Growth Fund
    Company & Industry Overviews

    Behind the Fidelity Blue Chip Growth Fund’s Disappointing Performance in 2016

    FBGRX has had a below-average 2016 so far, placing seventh in our select peer group of 12 funds in terms of point-to-point returns.

    By David Ashworth
  • uploads///Fidelity Blue Chip Growth Fund
    Company & Industry Overviews

    What’s Been Ailing the Fidelity Blue Chip Growth Fund?

    Stock picks from the healthcare sector are primarily responsible for FBGRX’s poor showing YTD. Allergan has hurt the sector, with Regeneron and Celgene.

    By David Ashworth
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.